Suppr超能文献

[俄罗斯通用实时荧光定量PCR试剂套装的特性及其在分子肿瘤诊断中的应用]

[Characterization of the universal Russian reagent sets for real-time PCR and its application for molecular oncodiagnostic].

作者信息

Manzeniuk O Iu, Malakho S G, Pekhov V M, Kosorukova I S, Poltaraus A B

出版信息

Mol Biol (Mosk). 2006 Mar-Apr;40(2):349-56.

Abstract

Universal Russian reagents for real time PCR were tested and compared with reference reagents provided by foreign companies. Testing was carried out on plasmids with cloning fragments (DNA-standards) of cDNA with chimeric (fusion) gene PML-RARalpha. Values of amplification efficiency of Russian and foreign reagents were measured on samples with serial dilutions (30-300000 copies) of cloned cDNA fragments of PML-RARalpha and internal control gene ABL. Amplification efficiencies of Russian and foreign reagents were found to be close one to another. Russian universal reagent kit RealityTM and ABI TaqMan Core Reagent Kit have amplification efficiencies 1.919 and 1.929, and correlation coefficients of copy numbers PML-RARalpha0.999 and 0.996, respectively. These values were determined by construction of a standard curve. To verify these results we studied also the samples of cDNA from blood and bone marrow of patients with acute promyelocytic leukemia. All samples posses translocation t(15;17), and appropriate chimeric gene PML-RARalpha. copy number in 1 microg of total RNA was in range 5.86 x 10(4)-8.315 x 10(5) before chemotherapy. No symptoms of minimal residual disease were found after 3.5 months since chemotherapy - fusion gene PML-RARalpha was not detected by real time PCR method. These results are in agreement with clinical data. Our investigations tend to show that application of RealityTM reagent set in real timePCR experiments gives correct results and may be used in molecular oncodiagnostics.

摘要

对通用的俄罗斯实时荧光定量PCR试剂进行了测试,并与外国公司提供的参考试剂进行了比较。测试是在含有嵌合(融合)基因PML-RARα的cDNA克隆片段(DNA标准品)的质粒上进行的。在含有PML-RARα和内参基因ABL的克隆cDNA片段系列稀释(30 - 300000拷贝)的样本上,测定了俄罗斯试剂和外国试剂的扩增效率。发现俄罗斯试剂和外国试剂的扩增效率彼此接近。俄罗斯通用试剂试剂盒RealityTM和ABI TaqMan核心试剂试剂盒的扩增效率分别为1.919和1.929,PML-RARα拷贝数的相关系数分别为0.999和0.996。这些值是通过构建标准曲线确定的。为了验证这些结果,我们还研究了急性早幼粒细胞白血病患者血液和骨髓的cDNA样本。所有样本均具有t(15;17)易位以及相应的嵌合基因PML-RARα。化疗前每微克总RNA中的拷贝数范围为5.86×10⁴ - 8.315×10⁵。化疗3.5个月后未发现微小残留病症状——实时荧光定量PCR法未检测到融合基因PML-RARα。这些结果与临床数据一致。我们的研究倾向于表明,在实时荧光定量PCR实验中应用RealityTM试剂套装能给出正确结果,可用于分子肿瘤诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验